Cree encephalitis is allelic with Aicardi-Goutiéres syndrome : implications for the pathogenesis of disorders of interferon alpha metabolism
Aicardi-Goutiéres syndrome (AGS) is an early onset, progressive encephalopathy characterised by calcification of the basal ganglia, white matter abnormalities, and a chronic cerebrospinal fluid (CSF) lymphocytosis. Cree encephalitis shows phenotypic overlap with AGS although the conditions have been considered distinct because of immunological abnormalities observed in Cree encephalitis. We report that levels of interferon alpha (IFN-alpha), a marker of AGS, are raised in Cree encephalitis. Moreover, linkage analysis indicates that the disorders are allelic and refines the AGS1 locus to a 3.47 cM critical interval. Our data show that a CSF lymphocytosis is not necessary for the diagnosis of AGS and strongly suggest that AGS and pseudo-TORCH syndrome are the same disorder. Recognition of immunological dysfunction as part of the AGS phenotype provides further evidence of a primary pathogenic role for abnormal IFN-alpha production in AGS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2003 |
|---|---|
| Erschienen: |
2003 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Journal of medical genetics - 40(2003), 3 vom: 09. März, Seite 183-7 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Crow, Y J [VerfasserIn] |
|---|
| Themen: |
Interferon-alpha |
|---|
| Anmerkungen: |
Date Completed 18.03.2003 Date Revised 03.05.2019 published: Print OMIM: 225750 Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM123991749 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM123991749 | ||
| 003 | DE-627 | ||
| 005 | 20231222202554.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231222s2003 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0413.xml |
| 035 | |a (DE-627)NLM123991749 | ||
| 035 | |a (NLM)12624136 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Crow, Y J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cree encephalitis is allelic with Aicardi-Goutiéres syndrome |b implications for the pathogenesis of disorders of interferon alpha metabolism |
| 264 | 1 | |c 2003 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2003 | ||
| 500 | |a Date Revised 03.05.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a OMIM: 225750 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Aicardi-Goutiéres syndrome (AGS) is an early onset, progressive encephalopathy characterised by calcification of the basal ganglia, white matter abnormalities, and a chronic cerebrospinal fluid (CSF) lymphocytosis. Cree encephalitis shows phenotypic overlap with AGS although the conditions have been considered distinct because of immunological abnormalities observed in Cree encephalitis. We report that levels of interferon alpha (IFN-alpha), a marker of AGS, are raised in Cree encephalitis. Moreover, linkage analysis indicates that the disorders are allelic and refines the AGS1 locus to a 3.47 cM critical interval. Our data show that a CSF lymphocytosis is not necessary for the diagnosis of AGS and strongly suggest that AGS and pseudo-TORCH syndrome are the same disorder. Recognition of immunological dysfunction as part of the AGS phenotype provides further evidence of a primary pathogenic role for abnormal IFN-alpha production in AGS | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Interferon-alpha |2 NLM | |
| 700 | 1 | |a Black, D N |e verfasserin |4 aut | |
| 700 | 1 | |a Ali, M |e verfasserin |4 aut | |
| 700 | 1 | |a Bond, J |e verfasserin |4 aut | |
| 700 | 1 | |a Jackson, A P |e verfasserin |4 aut | |
| 700 | 1 | |a Lefson, M |e verfasserin |4 aut | |
| 700 | 1 | |a Michaud, J |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, E |e verfasserin |4 aut | |
| 700 | 1 | |a Stephenson, J B P |e verfasserin |4 aut | |
| 700 | 1 | |a Woods, C G |e verfasserin |4 aut | |
| 700 | 1 | |a Lebon, P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical genetics |d 1964 |g 40(2003), 3 vom: 09. März, Seite 183-7 |w (DE-627)NLM000228656 |x 1468-6244 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2003 |g number:3 |g day:09 |g month:03 |g pages:183-7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2003 |e 3 |b 09 |c 03 |h 183-7 | ||